NOVA1 anticorps (AA 6-174) (HRP)
-
- Antigène Voir toutes NOVA1 Anticorps
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Épitope
- AA 6-174
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NOVA1 est conjugé à/à la HRP
-
Application
- ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human RNA-binding protein Nova-1 protein (6-174AA)
- Isotype
- IgG
- Top Product
- Discover our top product NOVA1 Anticorps primaire
-
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (AA 295-510) antibody
NOVA1 Reactivité: Humain WB, IHC, ICC, IP Hôte: Lapin Polyclonal unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (Internal Region) antibodyVerified NOVA1 Reactivité: Humain WB, ELISA, IHC Hôte: Chèvre Polyclonal unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (AA 1-507) antibodyNOVA1 Reactivité: Humain WB, ELISA Hôte: Souris Monoclonal 3F7 unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (AA 6-174) antibodyNOVA1 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (AA 139-173) antibodyNOVA1 Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB50876 unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (AA 408-507) antibodyNOVA1 Reactivité: Humain WB, ELISA Hôte: Souris Polyclonal unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) (C-Term) antibodyNOVA1 Reactivité: Humain WB, ICC, IF Hôte: Lapin Polyclonal unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) antibodyMicroarray verified NOVA1 Reactivité: Humain, Souris IHC Hôte: Souris Monoclonal MAB363915 unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) antibodyMicroarray verified NOVA1 Reactivité: Humain, Souris IHC Hôte: Souris Monoclonal MAB312777 unconjugated
anti-Neuro-Oncological Ventral Antigen 1 (NOVA1) antibodyMicroarray verified NOVA1 Reactivité: Humain, Souris IHC Hôte: Souris Monoclonal MAB309429 unconjugated
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Autre désignation
- NOVA1 (NOVA1 Produits)
- Synonymes
- anticorps Nova-1, anticorps NOVA1, anticorps si:ch211-222c22.9, anticorps 9430099M15Rik, anticorps G630039L02, anticorps NOVA alternative splicing regulator 1, anticorps neuro-oncological ventral antigen 1 L homeolog, anticorps neuro-oncological ventral antigen 1, anticorps RNA-binding protein Nova-1, anticorps lipid A export ATP-binding/permease protein, anticorps NOVA1, anticorps Nova1, anticorps nova1.L, anticorps nova1, anticorps LOC790874, anticorps novA1
- Sujet
-
Background: May regulate RNA splicing or metabolism in a specific subset of developing neurons.
Aliases: Neuro oncological ventral antigen 1 antibody, Neuro-oncological ventral antigen 1 antibody, NOVA 1 antibody, Nova-1 antibody, Nova1 antibody, NOVA1_HUMAN antibody, Onconeural ventral antigen 1 antibody, Paraneoplastic Ri antigen antibody, RNA binding protein Nova 1 antibody, RNA-binding protein Nova-1 antibody, Ventral neuron specific protein 1 antibody, Ventral neuron-specific protein 1 antibody
- UniProt
- P51513
-
